Heidelberg Pharma AG (FRA:HPHA)

Heidelberg Pharma AG Statistics

Total Valuation

FRA:HPHA has a market cap or net worth of EUR 142.61 million. The enterprise value is 119.87 million.

Market Cap	142.61M
Enterprise Value	119.87M

Important Dates

The last earnings date was Friday, October 10, 2025.

Earnings Date	Oct 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.60M
Shares Outstanding	n/a
Shares Change (YoY)	+2.26%
Shares Change (QoQ)	-0.81%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	0.73%
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	46.95
PB Ratio	13.54
P/TBV Ratio	84.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.58
EV / Sales	39.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.75

Financial Position

The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.01.

Current Ratio	5.85
Quick Ratio	3.48
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-6,756.44

Financial Efficiency

Return on equity (ROE) is -112.95% and return on invested capital (ROIC) is -83.00%.

Return on Equity (ROE)	-112.95%
Return on Assets (ROA)	-32.31%
Return on Invested Capital (ROIC)	-83.00%
Return on Capital Employed (ROCE)	-65.82%
Revenue Per Employee	26,644
Profits Per Employee	-229,629
Employee Count	105
Asset Turnover	0.05
Inventory Turnover	0.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.62%
50-Day Moving Average	3.44
200-Day Moving Average	3.29
Relative Strength Index (RSI)	33.00
Average Volume (20 Days)	399

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:HPHA had revenue of EUR 3.04 million and -26.18 million in losses. Loss per share was -0.55.

Revenue	3.04M
Gross Profit	2.57M
Operating Income	-30.97M
Pretax Income	-26.18M
Net Income	-26.18M
EBITDA	-30.24M
EBIT	-30.97M
Loss Per Share	-0.55

Balance Sheet

The company has 22.87 million in cash and 130,899 in debt, giving a net cash position of 22.74 million.

Cash & Cash Equivalents	22.87M
Total Debt	130,899
Net Cash	22.74M
Net Cash Per Share	n/a
Equity (Book Value)	10.53M
Book Value Per Share	0.22
Working Capital	33.95M

Cash Flow

In the last 12 months, operating cash flow was -31.66 million and capital expenditures -339,426, giving a free cash flow of -32.00 million.

Operating Cash Flow	-31.66M
Capital Expenditures	-339,426
Free Cash Flow	-32.00M
FCF Per Share	n/a

Margins

Gross Margin	84.66%
Operating Margin	-1,019.65%
Pretax Margin	-861.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:HPHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.26%
Shareholder Yield	-2.26%
Earnings Yield	-18.36%
FCF Yield	-22.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

FRA:HPHA has an Altman Z-Score of -8.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.25
Piotroski F-Score	1